BC-1485
BC-1485 is a small molecule inhibitor of Fibrosis-inducing E3 ligase 1 (FIEL1) . BC-1485 protects PIAS4 from ubiquitin-mediated degradation. BC-1485 decreases α-SMA, BAL and CXCL1. BC-1485 ameliorates fibrotic lung injury in murine models[1][2].
Product Specifications
CAS Number
2035085-19-7
UNSPSC
12352005
Target
CXCR
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Field of Research
Others
Smiles
O=C(NC(C)C(N(C)C)=O)C1=CC=C(NS(=O)(C2=CC=C(N3)C(NC3=O)=C2)=O)C=C1
Molecular Formula
C19H21N5O5S
Molecular Weight
431.47
References & Citations
[1]Lear T, et al. Ubiquitin E3 ligase FIEL1 regulates fibrotic lung injury through SUMO-E3 ligase PIAS4. J Exp Med. 2016 May 30;213 (6) :1029-46.|[2]Lear T, et al. Therapeutic targets in fibrotic pathways. Cytokine. 2016 Dec;88:193-195.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CXCR1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6209723-01 0.1 mL
AVPR1A (Vasopressin V1a Receptor, V1aR, VPR V1a, Antidiuretic Hormone Receptor 1a, Vascular/Hepatic-type Arginine Vasopressin Receptor, AVPR1) (MaxLight 550)
Sign In for Pricing
View Details MBS6209723-02 5x 0.1 mL
AVPR1A (Vasopressin V1a Receptor, V1aR, VPR V1a, Antidiuretic Hormone Receptor 1a, Vascular/Hepatic-type Arginine Vasopressin Receptor, AVPR1) (MaxLight 550)
Sign In for Pricing
View Details 
